Pharmaceutical Manufacturing Handbook: Production and

REFERENCES 555
of a model protein (human serum albumin) on poly(methylidene malonate 2.1.2)
nanoparticles , Pharm. Res. , 16 ( 1 ), 141 – 147 .
32. Lin , W. , Garnett , M. C. , Davis , S. S. , Schacht , E. , Ferruti , P. , and Illum , L. ( 2001 ), Preparation
and characterisation of rose Bengal - loaded surface - modifi ed albumin nanoparticles ,
J. Controlled Release , 71 ( 1 ), 117 – 126 .
33. Langer , K. , Balthasar , S. , Vogel , V. , Dinauer , N. , von Briesen , H. , and Schubert , D. ( 2003 ),
Optimization of the preparation process for human serum albumin (HSA) nanoparticles
, Int. J. Pharm. , 257 ( 1 – 2 ), 169 – 180 .
34. Mamone , G. , Addeo , F. , Chianese , L. , Di Luccia , A. , De Martino , A. , Nappo , A. ,
Formisano , A. , De Vivo , P. , and Ferranti , P. ( 2005 ), Characterization of wheat gliadin
proteins by combined two - dimensional gel electrophoresis and tandem mass spectrometry
, Proteomics , 5 ( 11 ), 2859 – 2865 .
35. Ezpeleta , I. , Irache , J. M. , Stainmesse , S. , Chabenat , C. , Gueguen , J. , Popineau , Y. , and
Orecchioni , A. ( 1996 ), Gliadin nanoparticles for the controlled release of all - trans -
retinoic acid , Int. J. Pharm. , 131 ( 2 ), 191 – 200 .
36. Wieser , H. ( 1996 ), Relation between gliadin structure and coeliac toxicity , Acta Paediatr.
Suppl. , 412 , 3 – 9 .
37. Lambert , G. , Fattal , E. , and Couvreur , P. ( 2001 ), Nanoparticulate systems for the delivery
of antisense oligonucleotides , Adv. Drug Deliv. Rev. , 47 ( 1 ), 99 – 112 .
38. Bodmeier , R. , Chen , H. G. , and Paeratakul , O. ( 1989 ), A novel approach to the oral
delivery of micro - or nanoparticles , Pharm. Res. , 6 ( 5 ), 413 – 417 .
39. Douglas , K. L. , and Tabrizian , M. ( 2005 ), Effect of experimental parameters on the formation
of alginate - chitosan nanoparticles and evaluation of their potential application
as DNA carrier , J. Biomater. Sci. Polym. Ed. , 16 ( 1 ), 43 – 56 .
40. Borges , O. , Borchard , G. , Verhoef , J. C. , de Sousa , A. , and Junginger , H. E. ( 2005 ), Preparation
of coated nanoparticles for a new mucosal vaccine delivery system , Int. J. Pharm. ,
299 ( 1 – 2 ), 155 – 166 .
41. Pandey , R. , Ahmad , Z. , Sharma , S. , and Khuller , G. K. ( 2005 ), Nano - encapsulation of
azole antifungals: Potential applications to improve oral drug delivery , Int. J. Pharm. ,
301 ( 1 – 2 ), 268 – 276 .
42. Zahoor , A. , Sharma , S. , and Khuller , G. K. ( 2005 ), Inhalable alginate nanoparticles as
antitubercular drug carriers against experimental tuberculosis , Int. J. Antimicrob. Agents ,
26 ( 4 ), 298 – 303 .
43. Yi , Y. M. , Yang , T. Y. , and Pan , W. M. ( 1999 ), Preparation and distribution of 5 -
fl uorouracil (125)I sodium alginate - bovine serum albumin nanoparticles , World J. Gastroenterol.
5 ( 1 ), 57 – 60 .
44. Ahmad , Z. , Pandey , R. , Sharma , S. , and Khuller , G. K. ( 2006 ), Pharmacokinetic and
pharmacodynamic behaviour of antitubercular drugs encapsulated in alginate nanoparticles
at two doses , Int. J. Antimicrob. Agents , 27 ( 5 ), 409 – 416 .
45. Borges , O. , Cordeiro - da - Silva , A. , Romeijn , S. G. , Amidi , M. , de Sousa , A. , Borchard , G. ,
and Junginger , H. E. ( 2006 ), Uptake studies in rat Peyer ’ s patches, cytotoxicity and
release studies of alginate coated chitosan nanoparticles for mucosal vaccination ,
J. Controlled Release , 114 ( 3 ), 348 – 358 .
46. Holtan , S. , Zhang , Q. , Strand , W. I. , and Skjak - Braek , G. ( 2006 ), Characterization of the
hydrolysis mechanism of polyalternating alginate in weak acid and assignment of the
resulting MG - oligosaccharides by NMR spectroscopy and ESI - mass spectrometry , Biomacromolecules
, 7 ( 7 ), 2108 – 2121 .
47. Chen , L. , and Subirade , M. ( 2005 ), Chitosan/beta - lactoglobulin core - shell nanoparticles
as nutraceutical carriers , Biomaterials , 26 ( 30 ), 6041 – 6053 .